Guizhou Xinbang Pharmaceutical Co., Ltd. (002390.SZ) SHZ
Currency In CNY
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In CNY
| Market Cap | 6.11B |
| Enterprise Value | 5.67B |
| P/E Ratio | 43.81 |
| PEG Ratio | 0.83 |
| Price/Sales Ratio | 1.01 |
| Price/Book Ratio | 0.78 |
| Enterprise/Revenue | 0.91 |
| Enterprise/EBITDA | 13.61 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
| Profit Margin | 0.02 |
| Operating Margin | 0.04 |
| Return On Assets | 0.01 |
| Return On Equity | 0.02 |
| Revenue | 5.61B |
| Revenue/Share | 2.87 |
| Gross Profit | 877.77M |
| EBITDA | 464.2M |
| Net Income | 120.29M |
| Diluted EPS | 0.06 |
| Total Cash | 1.15B |
| Total Cash/Share | 0.61 |
| Total Debt | 618.72M |
| Total Debt/Equity | 0.09 |
| Current Ratio | 3.5 |
| Book Value Per Share | 3.75 |
| 52-Week Change | -17.01 |
| 52-Week High | 4.15 |
| 52-Week Low | 2.65 |
| Moving Average 50 Days | 3.12 |
| Moving Average 200 Days | 3.42 |
| Average Volume | 27.35M |
| Shares Outstanding | 1.94B |
| % Held by Institutions | N/A |
| Trailing Annual Dividend Rate | 0.09 |
| Trailing Annual Dividend Yield | 3.18 |
| Payout Ratio | 1.8 |
| Last Split Factor | 5:2 |
| Last Split Date | May 25, 2015 |